Rare Plant Stops Tumor Growth in Lab

The compound works like a key in a molecular lock. It inhibits the action of a cancer-linked protein called RSK, which the researchers discovered is important for controlling the growth of breast cancer cells. However, SL0101 does not alter the growth of normal breast cells.

"By preventing RSK from working, we completely stopped the growth of breast cancer cells but did not affect the growth of normal breast cells,” said Deborah Lannigan, assistant professor of microbiology at the University of Virginia Cancer Center (Charlottesville, USA). Dr. Lannigan and Jeffrey Smith, a research assistant professor of pathology at the center, have begun testing the compound in animal models. Their work was reported in the February 1, 2005, issue of Cancer Research.

"We will modify the structure of SL0101, if necessary, to eventually find a compound that can be carried through to human clinical trials,” said Dr. Smith. "But human trials will likely be years down the road.”





Related Links:
U. of Virginia Cancer Center